这是一篇来自已证抗体库的有关人类 alpha-catenin的综述，是根据36篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合alpha-catenin 抗体。
alpha-catenin 同义词: CAP102; MDPT2

赛默飞世尔
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫细胞化学; 人类; 1:250; 图 4b
赛默飞世尔 alpha-catenin抗体（Thermo Fisher Scientific, 13-9700)被用于被用于免疫细胞化学在人类样本上浓度为1:250 (图 4b). Proc Natl Acad Sci U S A (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 非洲爪蛙; 图 2a
赛默飞世尔 alpha-catenin抗体（Thermo Scientific, PA1-25081)被用于被用于免疫组化在非洲爪蛙样本上 (图 2a). Sci Rep (2017) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化; 大鼠; 1:100
赛默飞世尔 alpha-catenin抗体（Invitrogen, 13-9700)被用于被用于免疫组化在大鼠样本上浓度为1:100. FASEB J (2015) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 alpha-catenin抗体（Zymed/Invitrogen, alphaCAT-7A4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Anticancer Res (2015) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 alpha-catenin抗体（Zymed Inc, alpha CAT-7A4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Clin Exp Metastasis (2015) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化; 大鼠; 1:100
赛默飞世尔 alpha-catenin抗体（Zymed/Invitrogen, 13-9700)被用于被用于免疫组化在大鼠样本上浓度为1:100. PLoS ONE (2013) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫细胞化学; 小鼠; 1:100; 图 s5
  • 免疫组化; 小鼠; 1:100; 图 s3h
赛默飞世尔 alpha-catenin抗体（Zymed, aCAT-7A4)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 s5) 和 被用于免疫组化在小鼠样本上浓度为1:100 (图 s3h). Dev Cell (2010) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 alpha-catenin抗体（Zymed, alpha Cat-7A4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Int J Surg Pathol (2009) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-冰冻切片; 大鼠
赛默飞世尔 alpha-catenin抗体（Zymed Laboratories, 13-9700)被用于被用于免疫组化-冰冻切片在大鼠样本上. Histochem Cell Biol (2008) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1
赛默飞世尔 alpha-catenin抗体（Zymed, a CAT-7a4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1). Pathol Res Pract (2007) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-冰冻切片; 小鼠; 1:100
赛默飞世尔 alpha-catenin抗体（Invitrogen, 13-9700)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100. J Comp Neurol (2006) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫细胞化学; 小鼠; 图 1
  • 免疫印迹; 小鼠; 图 1
赛默飞世尔 alpha-catenin抗体（Zymed, alphaCAT-7A4)被用于被用于免疫细胞化学在小鼠样本上 (图 1) 和 被用于免疫印迹在小鼠样本上 (图 1). J Cell Sci (2005) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-冰冻切片; 人类
赛默飞世尔 alpha-catenin抗体（Zymed, 7A4)被用于被用于免疫组化-冰冻切片在人类样本上. Heart Rhythm (2004) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-石蜡切片; 人类; 1:50; 表 1
赛默飞世尔 alpha-catenin抗体（ZYMED, alphaCAT-7A4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 1). Gynecol Oncol (2004) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-石蜡切片; 人类; 1:100; 表 4
赛默飞世尔 alpha-catenin抗体（Zymed, [alpha]-CAT-7A4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 4). J Clin Gastroenterol (2004) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫印迹; 小鼠; 图 8
赛默飞世尔 alpha-catenin抗体（Zymed Laboratories, clone alphaCAT-7A4)被用于被用于免疫印迹在小鼠样本上 (图 8). J Biol Chem (2001) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫细胞化学; 人类
赛默飞世尔 alpha-catenin抗体（Zymed, CAT-7A4)被用于被用于免疫细胞化学在人类样本上. J Cell Biol (2000) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫组化-冰冻切片; 人类
赛默飞世尔 alpha-catenin抗体（Zymed, aCAT-7A4)被用于被用于免疫组化-冰冻切片在人类样本上. Invest Ophthalmol Vis Sci (1999) ncbi
小鼠 单克隆（alpha-CAT-7A4）
  • 免疫印迹; 人类
赛默飞世尔 alpha-catenin抗体（Zymed, aCAT-7A4)被用于被用于免疫印迹在人类样本上. Am J Pathol (1999) ncbi
圣克鲁斯生物技术
小鼠 单克隆（G-11）
  • 免疫细胞化学; 人类; 图 2c
  • 免疫印迹; 人类; 图 2b, s2b
圣克鲁斯生物技术 alpha-catenin抗体（Santa Cruz, sc-9988)被用于被用于免疫细胞化学在人类样本上 (图 2c) 和 被用于免疫印迹在人类样本上 (图 2b, s2b). iScience (2020) ncbi
小鼠 单克隆（G-11）
  • 免疫细胞化学; 人类; 图 1f
  • 免疫印迹; 人类; 图 1g
圣克鲁斯生物技术 alpha-catenin抗体（Santa, sc-9988)被用于被用于免疫细胞化学在人类样本上 (图 1f) 和 被用于免疫印迹在人类样本上 (图 1g). J Mol Cell Cardiol (2019) ncbi
小鼠 单克隆（G-11）
  • 免疫组化; 人类; 1:200; 图 2e
  • 免疫印迹; 人类; 图 1c
  • 免疫组化; 小鼠; 1:200; 图 8f
  • 免疫印迹; 小鼠; 图 8d
圣克鲁斯生物技术 alpha-catenin抗体（Santa Cruz, SC-9988)被用于被用于免疫组化在人类样本上浓度为1:200 (图 2e), 被用于免疫印迹在人类样本上 (图 1c), 被用于免疫组化在小鼠样本上浓度为1:200 (图 8f) 和 被用于免疫印迹在小鼠样本上 (图 8d). Redox Biol (2017) ncbi
艾博抗（上海）贸易有限公司
domestic rabbit 单克隆（EP1793Y）
  • 免疫印迹; 人类; 1:5000; 图 4d
艾博抗（上海）贸易有限公司 alpha-catenin抗体（Abcam, ab51032)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 4d). Aging (Albany NY) (2016) ncbi
domestic rabbit 单克隆（EP1793Y）
  • 免疫组化-石蜡切片; 小鼠; 1:2000; 图 ev3a3
艾博抗（上海）贸易有限公司 alpha-catenin抗体（Abcam, ab51032)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:2000 (图 ev3a3). EMBO Rep (2015) ncbi
domestic rabbit 单克隆（EP1793Y）
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
艾博抗（上海）贸易有限公司 alpha-catenin抗体（Abcam, ab51032)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Oncogene (2015) ncbi
Enzo Life Sciences
小鼠 单克隆（15D9）
  • 免疫细胞化学; 小鼠; 1:100; 图 1d
Enzo Life Sciences alpha-catenin抗体（Enzo, ALX-804-101-C100)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 1d). J Cell Sci (2019) ncbi
小鼠 单克隆（15D9）
  • 免疫组化; 人类; 图 1
Enzo Life Sciences alpha-catenin抗体（Enzo Life Sciences, ALX-804-101-C100)被用于被用于免疫组化在人类样本上 (图 1). Nat Cell Biol (2015) ncbi
赛信通（上海）生物试剂有限公司
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 1:200; 图 4g
  • 免疫印迹; 人类; 1:1000; 图 2a
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 s1d
赛信通（上海）生物试剂有限公司 alpha-catenin抗体（Cell Signaling, 3236)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 4g), 被用于免疫印迹在人类样本上浓度为1:1000 (图 2a) 和 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 s1d). J Biol Chem (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1b
赛信通（上海）生物试剂有限公司 alpha-catenin抗体（Cell Signaling, 3236)被用于被用于免疫印迹在小鼠样本上 (图 1b). Nature (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s2b
赛信通（上海）生物试剂有限公司 alpha-catenin抗体（Cell Signaling, 3236)被用于被用于免疫印迹在人类样本上 (图 s2b). J Mol Cell Biol (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200; 图 6h
赛信通（上海）生物试剂有限公司 alpha-catenin抗体（Cell Signaling, 3236)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 6h). J Cell Biol (2018) ncbi
  • 免疫印迹; 人类; 图 1b
赛信通（上海）生物试剂有限公司 alpha-catenin抗体（Cell signaling, 2951S)被用于被用于免疫印迹在人类样本上 (图 1b). Oncotarget (2016) ncbi
domestic rabbit 单克隆（23B2）
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类; 图 s4b
赛信通（上海）生物试剂有限公司 alpha-catenin抗体（Cell Signaling, 23B2)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上 (图 s4b). J Clin Invest (2016) ncbi
Bioworld
  • 免疫印迹; 人类; 图 5
Bioworld alpha-catenin抗体（Bioworld Tech, BS4739)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
碧迪BD
小鼠 单克隆（30/?-Catenin）
  • 免疫沉淀; 人类; 图 2
  • 免疫细胞化学; 人类; 图 2
  • 免疫印迹; 人类; 图 2
碧迪BD alpha-catenin抗体（BD Bioscience, 611537)被用于被用于免疫沉淀在人类样本上 (图 2), 被用于免疫细胞化学在人类样本上 (图 2) 和 被用于免疫印迹在人类样本上 (图 2). Sci Rep (2016) ncbi
小鼠 单克隆（30/?-Catenin）
  • 免疫印迹; 人类; 1:800
碧迪BD alpha-catenin抗体（BD Transduction Labs, 611537)被用于被用于免疫印迹在人类样本上浓度为1:800. J Biol Chem (2015) ncbi
文章列表
  1. Goswami S, Balasubramanian I, D Agostino L, Bandyopadhyay S, Patel R, Avasthi S, et al. RAB11A-mediated YAP localization to adherens and tight junctions is essential for colonic epithelial integrity. J Biol Chem. 2021;297:100848 pubmed 出版商
  2. Wijshake T, Zou Z, Chen B, Zhong L, Xiao G, Xie Y, et al. Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin. Proc Natl Acad Sci U S A. 2021;118: pubmed 出版商
  3. Ear J, Saklecha A, Rajapakse N, Choi J, Ghassemian M, Kufareva I, et al. Tyrosine-Based Signals Regulate the Assembly of Daple⋅PARD3 Complex at Cell-Cell Junctions. iScience. 2020;23:100859 pubmed 出版商
  4. Padmanaban V, Krol I, Suhail Y, Szczerba B, Aceto N, Bader J, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573:439-444 pubmed 出版商
  5. Wang R, Yu R, Zhu C, Lin H, Lu X, Wang H. Tubulin detyrosination promotes human trophoblast syncytium formation. J Mol Cell Biol. 2019;: pubmed 出版商
  6. Li Y, Merkel C, Zeng X, Heier J, Cantrell P, Sun M, et al. The N-cadherin interactome in primary cardiomyocytes as defined using quantitative proximity proteomics. J Cell Sci. 2019;132: pubmed 出版商
  7. Weng J, Yu L, Chen Z, Su H, Yu S, Zhang Y, et al. β-Catenin phosphorylation at Y654 and Y142 is crucial for high mobility group box-1 protein-induced pulmonary vascular hyperpermeability. J Mol Cell Cardiol. 2019;127:174-184 pubmed 出版商
  8. Hoefert J, Bjerke G, Wang D, Yi R. The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. J Cell Biol. 2018;217:2185-2204 pubmed 出版商
  9. Herbomel G, Hatte G, Roul J, Padilla Parra S, Tassan J, Tramier M. Actomyosin-generated tension on cadherin is similar between dividing and non-dividing epithelial cells in early Xenopus laevis embryos. Sci Rep. 2017;7:45058 pubmed 出版商
  10. Chattopadhyay R, Raghavan S, Rao G. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function. Redox Biol. 2017;12:438-455 pubmed 出版商
  11. Zeng L, Yang X, Wen Y, Mail S, Wang M, Zhang M, et al. Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma. Aging (Albany NY). 2016;8:1236-49 pubmed 出版商
  12. Zhang M, Linghu E, Zhan Q, He T, Cao B, Brock M, et al. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling. Oncotarget. 2016;7:17957-69 pubmed 出版商
  13. He Y, Ryu T, Shrestha N, Yuan T, Kim H, Shrestha H, et al. Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling. Sci Rep. 2016;6:21207 pubmed 出版商
  14. Al Thawadi H, Abu Kaoud N, Al Farsi H, Hoarau Véchot J, Rafii S, Rafii A, et al. VE-cadherin cleavage by ovarian cancer microparticles induces β-catenin phosphorylation in endothelial cells. Oncotarget. 2016;7:5289-305 pubmed 出版商
  15. Bowser J, Blackburn M, Shipley G, Molina J, Dunner K, Broaddus R. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. J Clin Invest. 2016;126:220-38 pubmed 出版商
  16. Dietrich J, Panavaite L, Günther S, Wennekamp S, Groner A, Pigge A, et al. Venus trap in the mouse embryo reveals distinct molecular dynamics underlying specification of first embryonic lineages. EMBO Rep. 2015;16:1005-21 pubmed 出版商
  17. Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed 出版商
  18. Figueira A, Gomes C, Vilhena H, Miranda S, Carvalheira J, de Matos A, et al. Characterization of α-, β- and p120-Catenin Expression in Feline Mammary Tissues and their Relation with E- and P-Cadherin. Anticancer Res. 2015;35:3361-9 pubmed
  19. Bazellières E, Conte V, Elosegui Artola A, Serra Picamal X, Bintanel Morcillo M, Roca Cusachs P, et al. Control of cell-cell forces and collective cell dynamics by the intercellular adhesome. Nat Cell Biol. 2015;17:409-20 pubmed 出版商
  20. Yuan L, Seong E, Beuscher J, Arikkath J. δ-Catenin Regulates Spine Architecture via Cadherin and PDZ-dependent Interactions. J Biol Chem. 2015;290:10947-57 pubmed 出版商
  21. da Silva S, Morand G, Alobaid F, Hier M, Mlynarek A, Alaoui Jamali M, et al. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis. 2015;32:55-63 pubmed 出版商
  22. Shriver M, Stroka K, Vitolo M, Martin S, Huso D, Konstantopoulos K, et al. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis. Oncogene. 2015;34:4248-59 pubmed 出版商
  23. Qian X, Mruk D, Cheng C. Rai14 (retinoic acid induced protein 14) is involved in regulating f-actin dynamics at the ectoplasmic specialization in the rat testis*. PLoS ONE. 2013;8:e60656 pubmed 出版商
  24. Gladden A, Hebert A, Schneeberger E, McClatchey A. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev Cell. 2010;19:727-39 pubmed 出版商
  25. Patriarca C, Colombo P, Pio Taronna A, Wesseling J, Franchi G, Guddo F, et al. Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1). Int J Surg Pathol. 2009;17:99-106 pubmed 出版商
  26. Uehara K, Uehara A. Localization of claudin-5 and ZO-1 in rat spleen sinus endothelial cells. Histochem Cell Biol. 2008;129:95-103 pubmed
  27. Canavese G, Bernardi A, Candelaresi G, Lovadina P, Amerio S, Rossetti V, et al. Expression of the E-cadherin-catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes. Pathol Res Pract. 2007;203:517-23 pubmed
  28. Akins M, Greer C. Axon behavior in the olfactory nerve reflects the involvement of catenin-cadherin mediated adhesion. J Comp Neurol. 2006;499:979-89 pubmed
  29. Kim Y, Sauer C, Testa K, Wahl J, Svoboda R, Johnson K, et al. Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex. J Cell Sci. 2005;118:3883-94 pubmed
  30. Kaplan S, Gard J, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 2004;1:3-11 pubmed
  31. Marques F, Fonsechi Carvasan G, de Angelo Andrade L, Bottcher Luiz F. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol. 2004;94:16-24 pubmed
  32. Song S, Kim S, Kim D, Son H, Rhee J, Kim Y. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. J Clin Gastroenterol. 2004;38:252-9 pubmed
  33. Carothers A, Melstrom K, Mueller J, Weyant M, Bertagnolli M. Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice. J Biol Chem. 2001;276:39094-102 pubmed
  34. Allport J, Muller W, Luscinskas F. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol. 2000;148:203-16 pubmed
  35. Spirin K, Ljubimov A, Castellon R, Wiedoeft O, Marano M, Sheppard D, et al. Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA. Invest Ophthalmol Vis Sci. 1999;40:3108-15 pubmed
  36. de Boer C, van Dorst E, van Krieken H, Jansen van Rhijn C, Warnaar S, Fleuren G, et al. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol. 1999;155:505-15 pubmed